Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q3 2018 · 10-Q
Revenue$234.04M$234.04M+2.7% vs Q3 2017 Net Income-$6.55M-$6.55MN/M vs Q3 2017 EPS Diluted-$0.12-$0.12N/M vs Q3 2017 Gross Profit$111,295,000+10.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$65,395,000+18.5% Free Cash Flowderived$38,824,000+6.9% Margins · derivedGross margin47.6%+3.2 pt vs Q3 2017
Operating margin0.4%−8.9 pt vs Q3 2017
Net margin-2.8%−9.6 pt vs Q3 2017
ended Dec 30, 2017 · filed Feb 6, 2018 · 38 d after period end